ArticleCase reports in infectious diseases2026
Cryptococcal Meningitis Beyond Immunosuppression: A Case Report in an Immunocompetent Individual.
Article in Case reports in infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cryptococcal Meningitis Beyond Immunosuppression: A Case Report in an Immunocompetent Individual.Case reports in infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cryptococcal meningitis is a life-threatening opportunistic fungal infection predominantly seen in immunocompromised hosts, yet it is increasingly recognized in apparently immunocompetent individuals. In tuberculosis-endemic regions, its diagnosis is frequently delayed or missed due to overlapping clinical and cerebrospinal fluid findings with tuberculous meningitis. Case Presentation: A 44-year-old immunocompetent woman presented with a two-month history of progressive diffuse headache and subjective bilateral lower limb weakness. Neurological examination was unremarkable, and initial cerebrospinal fluid analysis revealed marked hypoglycorrhachia (1 mg/dL), elevated protein (356 mg/dL), and lymphocytic pleocytosis. Brain imaging showed leptomeningeal enhancement without mass lesions. Despite negative microbiological testing for tuberculosis, empirical antituberculous therapy was initiated based on presumptive tuberculous meningitis. Pulmonary imaging demonstrated cavitary nodules and calcified lymph nodes. Lack of clinical improvement prompted further investigation; India ink staining and fungal culture of cerebrospinal fluid eventually confirmed Discussion: This case illustrates the diagnostic challenge of cryptococcal meningitis in immunocompetent patients, particularly in settings where tuberculous meningitis is common. Early reliance on India ink staining and fungal culture is essential when initial tuberculosis workup is negative or when response to antituberculous therapy is poor. The incidental detection of HHV-6 DNA likely represented viral reactivation without clinical significance. Conclusion: Cryptococcal meningitis must be considered in immunocompetent patients presenting with chronic meningitis, even in the absence of classic risk factors. Prompt mycological investigation can prevent diagnostic delays and improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.